A surge in bullish options trading has drawn significant attention to biotech firm Ocugen, with market participants taking substantial positions anticipating further share price appreciation. This unusual trading pattern raises questions about whether investors have identified genuine potential or are engaging in speculative bets on the company's future. Heavy Call Volume Signals Bullish SentimentTrading activity on Wednesday revealed extraordinary interest in Ocugen call options, with 4,393 contracts changing hands. Such concentrated options activity typically indicates strong conviction about near-term price movements. The convergence of strong clinical progress, international business development, and unusual trading activity presents a compelling narrative for Ocugen.